Predictors and Prognosis of End-Stage Hypertrophic Cardiomyopathy

Authors

Mohammad Ali Sadr AmeliMohammad Ali Sadr Ameli ORCID1, Azin AlizadehaslAzin Alizadehasl ORCID2, Sheida KeshavariSheida Keshavari ORCID3, Zohre RahbarZohre Rahbar ORCID3, Mahdi KhaliliMahdi Khalili ORCID4, Sepehr JamalkhaniSepehr Jamalkhani ORCID5, Zahra ShahidzadehZahra Shahidzadeh ORCID4, Marzie BazziMarzie Bazzi ORCID4, Nima SarisarrafNima Sarisarraf ORCID4, Masood ShekarchizadehMasood Shekarchizadeh ORCID4, Kamran RoudiniKamran Roudini ORCID6, Rasoul Azarfarin2, Robab AnbiaeeRobab Anbiaee ORCID7, Maedeh BarahmanMaedeh Barahman ORCID8, Zahra HosseiniZahra Hosseini ORCID1, Davood Khoda-AmorzidehDavood Khoda-Amorzideh ORCID2, Amir Abdi9, Hooman Bakhshandeh10, Alireza Alizadeh GhavidelAlireza Alizadeh Ghavidel ORCID11, Mina Mohseni2, Zohre Kahe3, Saideh JamshidiSaideh Jamshidi ORCID3,*
1Department of Interventional Cardiology, Rajaie Cardiovascular Medical and Research Center, Tehran, IR Iran
2Cardio-oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran, IR Iran
3Department of Echocardiography, Rajaie Cardiovascular Medical and Research Center, Tehran, IR Iran
4Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
5Cardiac Anesthesiology Department, Rajaie Cardiovascular Medical and Research Center, Tehran, IR Iran
6Hematooncology Department, Tehran University of Medical Sciences, Tehran, IR Iran
7Radio-Oncology Department, Shahid Beheshti University of Medical Science, Tehran, IR Iran
8Radio-Oncology Department, Iran University of Medical Science, Tehran, IR Iran
9Islamic Azad University of Medical Sciences, IR Iran
10Epidemiology Department, Iran University of Medical Sciences, Tehran, IR Iran
11Heart Valve Disease Research Center, Rajaie Cardiovascular Medical & Research Center, Iran University of Medical Sciences, Tehran, IR Iran
*Corresponding Author: Department of Echocardiography, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran. Cellphone: +98-9173128391, Email: [email protected].[email protected]

International Cardiovascular Research Journal:Vol. 16, issue 4; e130190
Published online:Dec 31, 2022
Article type:Research Article
Received:Jul 03, 2022
Accepted:Dec 28, 2022
How to Cite:Sadr Ameli MA, Alizadehasl A, Keshavari S, Rahbar Z, Khalili M, et al. Predictors and Prognosis of End-Stage Hypertrophic Cardiomyopathy. Int Cardiovasc Res J. 2022;16(4):e130190. doi:

Abstract

Background: Burned-out hypertrophic cardiomyopathy (BO-HCM) is complicated by substantial adverse events. However, few studies have focused on clinical or echocardiographic features and their prognostic values among patients with BO-HCM.

 

 

Objective: This study evaluated the clinical manifestations and prognostic value of echocardiography in patients with BO-HCM.

 

 

Methods: The present retrospective study evaluated 401 consecutive patients referred to the echocardiography ward of Rajaie Cardiovascular Center for evaluation of HCM during the period from January 2010 to February 2018. Three hundred six patients who completed the follow-up were included: 78 (25.4%) had BO-HCM and an EF of < 50% (group 1), and 228 (74.5%) had a normal EF in their baseline TTE (group 2). Among the group 2 population, 183 patients had a preserved EF of > 50% (group 2B), and 45 became BO-HCM at the end of their follow-up (group 2A). Clinical data were analyzed, including medical history, electrocardiography, and echocardiography. Generalized estimating equation (GEE) regression was performed to assess the association between patient characteristics and burned-out HCM.

 

 

Results: An atrial fibrillation (AF) rhythm was more common in the groups with BO-HCM (groups 1 and 2A) (32.8 vs. 14%; P = 0.002), as were Frequent premature ventricular contractions (PVCs) (13.98 vs. 5%; P = 0.040). Moderate or severe systolic anterior motion (SAM) was significantly more common in group 2B (LVEF > 50%) compared with group 1 and 2A, who had an EF of ≤ 50% (32.3% vs. 7.6%; P = 0.006). The S-wave of the right ventricle was significantly lower in groups 1 and 2A (9.73 vs. 11.8 cm/s; P < 0.001). Systolic pulmonary artery pressure (SPAP) was significantly higher in groups 1 and 2A (38.28 vs. 29.74 mmHg, P < 0.001). The differences in the prevalence of asymmetrical septal hypertrophy (ASH), left ventricular outlet (LVOT) obstruction, pericardial effusion (PE), diastolic dysfunction, and mitral regurgitation (MR) were insignificant between all groups.

 

 

 Conclusions: Among the patients suffering from HCM, the presence of AF rhythm, frequent PVCs, significant RV dysfunction, and absence of systolic anterior motion (SAM) of mitral valve leaflets have prognostic value and might be considered predictors for progression to BO-HCM.

 

 

Fulltext

The full-text is available in pdf.

References

  • 1.
    The references are available in pdf.

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

15
Jun
2022

Burned-out Phase in Apical Hypertrophic Cardiomyopathy (Echocardiographic Data of 230 Patients with Apical HCM)

Mohammad Ali Sadr Ameli,
Azin Alizadehasl,
Zohre Rahbar,
Maryam Maharlou,
Sepehr Jamalkhani,
Davood Khoda-Amorzideh
,et al.

Sadr Ameli MA, Alizadehasl A, Rahbar Z, Maharlou M, Jamalkhani S, et al. Burned-out Phase in Apical Hypertrophic Cardiomyopathy (Echocardiographic Data of 230 Patients with Apical HCM). Int Cardiovasc Res J. 2022;16(2):e122923. doi:

30
Sep
2009

Clinical and Echocardiographic Evaluation of Regional Systolic Function Detected by Tissue Doppler Imaging in Hypertrophic Cardiomyopathy

M Kiavar,
N Behzadnia,
Anita Sadeghpour,
Sh Maddadi

Kiavar M, Behzadnia N, Sadeghpour A, Maddadi S. Clinical and Echocardiographic Evaluation of Regional Systolic Function Detected by Tissue Doppler Imaging in Hypertrophic Cardiomyopathy. Int Cardiovasc Res J. 2009;3(3):e68032. doi:

1
Dec
2010

Left Ventricular Systolic Dyssynchrony in Patients with Hypertrophic Cardiomyopathy: The prevalence and its Relation to Syncope

A Sadeghpour,
M Kyavar,
N Behzadnia,
Sh Maddadi,
M Parsaei,
M Maleki
,et al.

Sadeghpour A, Kyavar M, Behzadnia N, Maddadi S, Parsaei M, et al. Left Ventricular Systolic Dyssynchrony in Patients with Hypertrophic Cardiomyopathy: The prevalence and its Relation to Syncope. Int Cardiovasc Res J. 2017;4(4):e58475. doi:

1
Mar
2016

Predictors of Right Ventricular Systolic Dysfunction in Non-Ischemic Dilated Cardiomyopathy: An Echocardiographic Study

Oğuz Karaca,
Anıl Avcı,
Gamze Babur G&uuml;ler,
Onur Omaygenc,
Beytullah Cakal,
Haci Murat Gunes
,et al.

Karaca O, Avcı A, Babur G&uuml;ler G, Omaygenc O, Cakal B, et al. Predictors of Right Ventricular Systolic Dysfunction in Non-Ischemic Dilated Cardiomyopathy: An Echocardiographic Study. Int Cardiovasc Res J. 2016;10(1):e10307. doi:

15
Jun
2020

Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Maryam Nabati,
Soheil Bakhshinasab,
Ali asghar Farsavian,
Fatemeh Rasolpor,
Jamshid Yazdani- Charati

Nabati M, Bakhshinasab S, Farsavian AA, Rasolpor F, Yazdani- Charati J. Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure. Int Cardiovasc Res J. 2020;14(2):e103597. doi:

More by these authors

Mohammad Ali Sadr AmeliPubMedScholar
Azin AlizadehaslPubMedScholar
Sheida KeshavariPubMedScholar
Zohre RahbarPubMedScholar
Mahdi KhaliliPubMedScholar
Sepehr JamalkhaniPubMedScholar
Zahra ShahidzadehPubMedScholar
Marzie BazziPubMedScholar
Nima SarisarrafPubMedScholar
Masood ShekarchizadehPubMedScholar
Kamran RoudiniPubMedScholar
Rasoul AzarfarinPubMedScholar
Robab AnbiaeePubMedScholar
Maedeh BarahmanPubMedScholar
Zahra HosseiniPubMedScholar
Davood Khoda-AmorzidehPubMedScholar
Amir AbdiPubMedScholar
Hooman BakhshandehPubMedScholar
Alireza Alizadeh GhavidelPubMedScholar
Mina MohseniPubMedScholar
Zohre KahePubMedScholar
Saideh JamshidiPubMedScholar
Share
Cited by
Metrics
Indexed in